Why International Business Machines Corporation (IBM) Is Being Added to Investors Watchlist?

International Business Machines Corporation (NYSE:IBM) has recently been identified as an interesting stock but more in-depth monitoring is needed for a trade decision. Now trading with a market value of 132.40B, the company has a mix of catalysts and obstacles that spring from the nature of its operations. In light of the many issues surrounding this company, we thought it was a good time to take a close look at the numbers in order to form a realistic perspective on the fundamental picture for this stock.

International Business Machines Corporation (NYSE:IBM) Fundamentals That Matter

It’s generally a good idea to start with the most fundamental piece of the picture: the balance sheet. The balance sheet health of any company plays a key role in its ability to meet its obligations and maintain the faith of its investment base. For IBM, the company currently has 11.7 billion of cash on the books, which is offset by 8.06 billion in current liabilities. The trend over time is important to note. In this case, the company’s debt has been falling. The company also has 120.5 billion in total assets, balanced by 101.95 billion in total liabilities, which should give you a sense of the viability of the company under any number of imagined business contexts.

International Business Machines Corporation (IBM) saw 2.78 billion in free cash flow last quarter, representing a quarterly net change in cash of 1.6 billion. Perhaps most importantly where cash movements are concerned, the company saw about 3.47 billion in net operating cash flow.

International Business Machines Corporation (NYSE:IBM) Revenue Growth Potential

As far as key trends that demonstrate something of the future investment potential of this stock, we need to take a closer look at the top line, first and foremost. Last quarter, the company saw 19.29 billion in total revenues. That represents a quarterly year/year change in revenues of -0.05 in sequential terms, the IBM saw sales decline by 0.06.

But what about the bottom line? After all, that’s what really matters in the end. International Business Machines Corporation (IBM) is intriguing when broken down to its core data. The cost of selling goods last quarter was 10.61 billion, yielding a gross basic income of 8.68 billion. For shareholders, given the total diluted outstanding shares of 939.6 million, this means overall earnings per share of 2.48. Note, this compares with a consensus analyst forecast of 3.29 in earnings per share for its next fiscal quarterly report.

Is International Business Machines Corporation (NYSE:IBM) Valuation Attractive

Looking ahead at valuations, according to the consensus, the next fiscal year is forecast to bring about 13.89 in total earnings per share. If we consider a median price to earnings ratio on the stock, that corresponds with a stock price of 10.23. However, one should always remember: the trends are more important than the forecasts. This continues to be an interesting story, and we look forward to updating it again soon on International Business Machines Corporation.

Previous ArticleNext Article

Related Post

Why Bed Bath & Beyond Inc. (BBBY) Is Being Ad... It is interesting to note that Bed Bath & Beyond Inc. (NASDAQ:BBBY) is active and made a solid movement in the last trading day. Now trading with ...
Looking at the Big Picture for The Meet Group, Inc... The Meet Group, Inc. (NASDAQ:MEET) is in the highlights and many would want to know whether now might be a good time for it to present much upside. No...
OvaScience, Inc. (OVAS): Does This Move Make Any S... OvaScience, Inc. (NASDAQ:OVAS)'s interesting series of developments are underway around the US stock market these days. Now trading with a market valu...
It’s worth it to have a look at Dick’s... It is interesting to note that Dick's Sporting Goods, Inc. (NYSE:DKS) is active and made a solid movement in the last trading day. Now trading with a ...
Analyzing the Insider Data for Arbutus Biopharma C... Recent insider trends for Arbutus Biopharma Corporation (NASDAQ:ABUS) have caught the attention of investors. Analysts study insider data to get a sen...